← Back to Clinical Trials
Recruiting NCT06430957

NCT06430957 OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06430957
Status Recruiting
Phase
Sponsor Kırıkkale University
Condition Obstructive Sleep Apnea Risk Management
Study Type OBSERVATIONAL
Enrollment 240 participants
Start Date 2024-06-28
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
The STOP-BANG questionnaire for determining OSA risk level.ASA recommended criteria for determining OSA risk level.Record of postoperative complications

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 240 participants in total. It began in 2024-06-28 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Obstructive sleep apnea (OSA) is a sleep-related respiratory dysfunction. The prevalence of OSA is increasing with the increasing rates of obesity and elderly population worldwide. Perioperative anesthesia management should be adjusted to improve patient safety in patients with OSA. In OSA patients, positive pressure ventilation support may be required in the preoperative period, various ventilation strategies may be required in the intraoperative period, different pharmacologic agents may need to be avoided, and intensive care unit follow-up or noninvasive ventilation support may be required in the postoperative period. However, it is reported that a significant percentage of OSA patients remain undiagnosed. ASA (American Society of Anesthesiologists) has reported the criteria that should be questioned in order to determine the risk of patients in terms of OSA and to initiate the diagnostic process in risky patients and to make appropriate anesthesiologic arrangements in the perioperative period. In addition, the STOP-BANG assessment scale, which is widely used all over the world in OSA risk assessment, is also used in OSA risk assessment. It is thought that dental caries and extraction needs may be higher in OSA patients, especially since open-mouth sleeping accompanies the situation. In this respect, it is also important for patients to be diagnosed with OSA as it may prevent dental damage due to open-mouth sleeping in the future. Identifying patients at risk for OSA and directing them to the diagnostic process is very important for patient safety. Within the scope of the study, the criteria recommended by ASA and STOP-BANG score will be evaluated and recorded. Risk stratification in terms of STOP-BANG questionnaire and ASA criteria will be done separately for each patient and for each classification method. Patients at high risk will be consulted to the relevant medical department in the preoperative period for further investigation and treatment. In addition, it is aimed to correlate the risk levels determined in the study with postoperative respiratory complications and recovery time.

Eligibility Criteria

Inclusion Criteria: * Patients between 18-80 years of age who apply to the anesthesia clinic for dental procedures planned to be performed under general anesthesia * Patients without a previous diagnosis of OSA Exclusion Criteria: * Individuals who do not want to participate in the study * Patients previously diagnosed with OSA * Necessity of emergency surgery

Contact & Investigator

Central Contact

Gözde Nur Erkan, Asst. Prof.

✉ dr.gozdenur@gmail.com

📞 +905054334692

Frequently Asked Questions

Who can join the NCT06430957 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Obstructive Sleep Apnea Risk Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06430957 currently recruiting?

Yes, NCT06430957 is actively recruiting participants. Contact the research team at dr.gozdenur@gmail.com for enrollment information.

Where is the NCT06430957 trial being conducted?

This trial is being conducted at Kayseri, Turkey (Türkiye), Kirikkale, Turkey (Türkiye).

Who is sponsoring the NCT06430957 clinical trial?

NCT06430957 is sponsored by Kırıkkale University. The trial plans to enroll 240 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology